Amgen and GSK said to be adding products on TrumpRx
Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run...
News / Analytics / Reviews
Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run...
Belgian biopharma company UCB (UCBJY) announced on Wednesday that its arthritis therapy Bimzelx outperformed AbbVie’s...
Topline results from a phase 1 study of AbbVie's (ABBV) amylin analogue ABBV-295 for obesity showed the candidate led to...
The U.S. Food and Drug Administration is reportedly easing some requirements for drugmakers developing copycat versions of...
For the second time in less than a year, Vinay Prasad, the head of the U.S. Food and Drug Administration’s vaccines unit,...
AbbVie (ABBV) said that a subcutaneous version of Skyrizi (risankizumab) for Crohn's disease met key goals in a phase 3...
The S&P 500 (SP500) closed in the red on Friday, after the week saw earnings reports from tech giants including Nvidia...
RBC Capital Markets has initiated coverage of AbbVie (ABBV) at outperform saying the company has underperformed based on...
AbbVie (ABBV) will spend $380M to build two new active pharmaceutical ingredient plants at its current grounds in North...
AbbVie (ABBV) said Friday that the U.S. Food and Drug Administration has approved a supplemental new drug application for...